Evaluation of 22 genetic variants with Crohn's Disease risk in the Ashkenazi Jewish population: a case-control study

BMC Medical Genetics

Volumn 12, Issue , 2011, Pages

  Peter, Inga ^a   Mitchell, Adele A ^a   Ozelius, Laurie ^a   Erazo, Monica ^a   Hu, Jianzhong ^a   Doheny, Dana ^a   Abreu, Maria T ^b   Present, Daniel H ^c   Ullman, Thomas ^c   Benkov, Keith ^c   Korelitz, Burton I ^d   Mayer, Lloyd ^c   Desnick, Robert J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c MOUNT SINAI MEDICAL CENTER   (United States)

^d LENOX HILL HOSPITAL   (United States)

Author keywords

Crohn's Disease Ashkenazi Jewish; Genetic risk score

Indexed keywords

AUTOPHAGY RELATED 16 LIKE 1; CASPASE RECRUITMENT DOMAIN PROTEIN 15; IMMUNITY RELATED GUANOSINE TRIPHOSPHATASE; INTERLEUKIN 12P40; INTERLEUKIN 23 RECEPTOR; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 2; PROSTAGLANDIN E RECEPTOR 4; PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NKX2.3; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL GROWTH INHIBITOR;

ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CROHN DISEASE; GENE FREQUENCY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; GENE LOCUS; GENETIC PREDISPOSITION; GENETICS; JEW; MULTIVARIATE ANALYSIS; POPULATION GENETICS; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS;

ALLELES; CASE-CONTROL STUDIES; CROHN DISEASE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; HUMANS; JEWS; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; REGRESSION ANALYSIS; ROC CURVE;

EID: 79955651296     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-12-63     Document Type: Article

References (46)

1. Shanahan F. Crohn's disease. Lancet 2002, 359(9300):62-69. 10.1016/S0140-6736(02)07284-7, 11809204.
2. Scaldaferri F, Fiocchi C. Inflammatory bowel disease: progress and current concepts of etiopathogenesis. J Dig Dis 2007, 8(4):171-178. 10.1111/j.1751-2980.2007.00310.x, 17970872.
3. Farmer RG, Michener WM, Mortimer EA. Studies of family history among patients with inflammatory bowel disease. Clin Gastroenterol 1980, 9(2):271-277.
4. Singer HC, Anderson JG, Frischer H, Kirsner JB. Familial aspects of inflammatory bowel disease. Gastroenterology 1971, 61(4):423-430.
5. Thompson NP, Driscoll R, Pounder RE, Wakefield AJ. Genetics versus environment in inflammatory bowel disease: results of a British twin study. BMJ 1996, 312(7023):95-96. 2349773, 8555939.
6. Tysk C, Lindberg E, Jarnerot G, Floderus-Myrhed B. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 1988, 29(7):990-996. 10.1136/gut.29.7.990, 1433769, 3396969.
7. Kurata JH, Kantor-Fish S, Frankl H, Godby P, Vadheim CM. Crohn's disease among ethnic groups in a large health maintenance organization. Gastroenterology 1992, 102(6):1940-1948.
8. Rotter JI, Yang H, Shohat T. Genetic complexities of inflammatory bowel disease and its distribution among the Jewish people. Genetic diversity among Jews: disease and markers at the DNA level 1992, 395-411. Oxford: Oxford University Press, Bonne-Tamir B, Adam A.
9. Yang H, McElree C, Roth MP, Shanahan F, Targan SR, Rotter JI. Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. Gut 1993, 34(4):517-524. 10.1136/gut.34.4.517, 1374314, 8491401.
10. Franke A, McGovern DP, Barrett JC, Wang K, Radford-Smith GL, Ahmad T, Lees CW, Balschun T, Lee J, Roberts R, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 2010, 42(12):1118-1125. 10.1038/ng.717, 21102463.
11. Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med 2009, 361(21):2066-2078. 10.1056/NEJMra0804647, 19923578.
12. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001, 411(6837):603-606. 10.1038/35079114, 11385577.
13. Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S, Frenzel H, King K, Hasselmeyer A, MacPherson AJ, et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001, 357(9272):1925-1928. 10.1016/S0140-6736(00)05063-7, 11425413.
14. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001, 411(6837):599-603. 10.1038/35079107, 11385576.
15. Economou M, Trikalinos TA, Loizou KT, Tsianos EV, Ioannidis JP. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol 2004, 99(12):2393-2404. 10.1111/j.1572-0241.2004.40304.x, 15571588.
16. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006, 314(5804):1461-1463. 10.1126/science.1135245, 17068223.
17. Rioux JD, Xavier RJ, Taylor KD, Silverberg MS, Goyette P, Huett A, Green T, Kuballa P, Barmada MM, Datta LW, et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 2007, 39(5):596-604. 10.1038/ng2032, 2757939, 17435756.
18. Libioulle C, Louis E, Hansoul S, Sandor C, Farnir F, Franchimont D, Vermeire S, Dewit O, de Vos M, Dixon A, et al. Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet 2007, 3(4):e58. 10.1371/journal.pgen.0030058, 1853118, 17447842.
19. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, Brant SR, Silverberg MS, Taylor KD, Barmada MM, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008, 40(8):955-962. 10.1038/ng.175, 2574810, 18587394.
20. Consortium WTCC Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447(7145):661-678. 10.1038/nature05911, 2719288, 17554300, Consortium WTCC.
21. Parkes M, Barrett JC, Prescott NJ, Tremelling M, Anderson CA, Fisher SA, Roberts RG, Nimmo ER, Cummings FR, Soars D, et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet 2007, 39(7):830-832. 10.1038/ng2061, 2628541, 17554261.
22. Yamazaki K, McGovern D, Ragoussis J, Paolucci M, Butler H, Jewell D, Cardon L, Takazoe M, Tanaka T, Ichimori T, et al. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum Mol Genet 2005, 14(22):3499-3506. 10.1093/hmg/ddi379, 16221758.
23. Mathur AN, Chang HC, Zisoulis DG, Stritesky GL, Yu Q, O'Malley JT, Kapur R, Levy DE, Kansas GS, Kaplan MH. Stat3 and Stat4 direct development of IL-17-secreting Th cells. J Immunol 2007, 178(8):4901-4907.
24. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989, 170:2-6. discussion 16-19.
25. Scott SA, Edelmann L, Liu L, Luo M, Desnick RJ, Kornreich R. Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases. Hum Mutat 2010, 31(11):1240-1250. 10.1002/humu.21327, 20672374.
26. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21(2):263-265. 10.1093/bioinformatics/bth457, 15297300.
27. McGovern DP, Butler H, Ahmad T, Paolucci M, van Heel DA, Negoro K, Hysi P, Ragoussis J, Travis SP, Cardon LR, et al. TUCAN (CARD8) genetic variants and inflammatory bowel disease. Gastroenterology 2006, 131(4):1190-1196. 10.1053/j.gastro.2006.08.008, 17030188.
28. Tukel T, Shalata A, Present D, Rachmilewitz D, Mayer L, Grant D, Risch N, Desnick RJ. Crohn disease: frequency and nature of CARD15 mutations in Ashkenazi and Sephardi/Oriental Jewish families. Am J Hum Genet 2004, 74(4):623-636. 10.1086/382226, 1181940, 15024686.
29. Sugimura K, Taylor KD, Lin YC, Hang T, Wang D, Tang YM, Fischel-Ghodsian N, Targan SR, Rotter JI, Yang H. A novel NOD2/CARD15 haplotype conferring risk for Crohn disease in Ashkenazi Jews. Am J Hum Genet 2003, 72(3):509-518. 10.1086/367848, 1180227, 12577202.
30. Lesage S, Zouali H, Cezard JP, Colombel JF, Belaiche J, Almer S, Tysk C, O'Morain C, Gassull M, Binder V, et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002, 70(4):845-857. 10.1086/339432, 379113, 11875755.
31. Kugathasan S, Baldassano RN, Bradfield JP, Sleiman PM, Imielinski M, Guthery SL, Cucchiara S, Kim CE, Frackelton EC, Annaiah K, et al. Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nat Genet 2008, 40(10):1211-1215. 10.1038/ng.203, 2770437, 18758464.
32. Silverberg MS, Cho JH, Rioux JD, McGovern DP, Wu J, Annese V, Achkar JP, Goyette P, Scott R, Xu W, et al. Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet 2009, 41(2):216-220. 10.1038/ng.275, 2652837, 19122664.
33. Cummings JR, Ahmad T, Geremia A, Beckly J, Cooney R, Hancock L, Pathan S, Guo C, Cardon LR, Jewell DP. Contribution of the novel inflammatory bowel disease gene IL23R to disease susceptibility and phenotype. Inflamm Bowel Dis 2007, 13(9):1063-1068. 10.1002/ibd.20180, 17508420.
34. Newman WG, Zhang Q, Liu X, Amos CI, Siminovitch KA. Genetic variants in IL-23R and ATG16L1 independently predispose to increased susceptibility to Crohn's disease in a Canadian population. J Clin Gastroenterol 2009, 43(5):444-447. 10.1097/MCG.0b013e318168bdf0, 19276991.
35. Anderson CA, Boucher G, Lees CW, Franke A, D'Amato M, Taylor KD, Lee JC, Goyette P, Imielinski M, Latiano A, et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 2011, 43(3):246-252. 10.1038/ng.764, 21297633.
36. Ahern PP, Schiering C, Buonocore S, McGeachy MJ, Cua DJ, Maloy KJ, Powrie F. Interleukin-23 drives intestinal inflammation through direct activity on T cells. Immunity 2010, 33(2):279-288. 10.1016/j.immuni.2010.08.010, 3078329, 20732640.
37. Palomino-Morales RJ, Oliver J, Gomez-Garcia M, Lopez-Nevot MA, Rodrigo L, Nieto A, Alizadeh BZ, Martin J. Association of ATG16L1 and IRGM genes polymorphisms with inflammatory bowel disease: a meta-analysis approach. Genes Immun 2009, 10(4):356-364. 10.1038/gene.2009.25, 19491842.
38. McCarroll SA, Huett A, Kuballa P, Chilewski SD, Landry A, Goyette P, Zody MC, Hall JL, Brant SR, Cho JH, et al. Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat Genet 2008, 40(9):1107-1112. 10.1038/ng.215, 2731799, 19165925.
39. Franke A, Hampe J, Rosenstiel P, Becker C, Wagner F, Hasler R, Little RD, Huse K, Ruether A, Balschun T, et al. Systematic association mapping identifies NELL1 as a novel IBD disease gene. PLoS ONE 2007, 2(1):e691. 1933598, 17684544.
40. Zhang HF, Qiu LX, Chen Y, Zhu WL, Mao C, Zhu LG, Zheng MH, Wang Y, Lei L, Shi J. ATG16L1 T300A polymorphism and Crohn's disease susceptibility: evidence from 13,022 cases and 17,532 controls. Hum Genet 2009, 125(5-6):627-631. 10.1007/s00439-009-0660-7, 19337756.
41. Marquez A, Nunez C, Martinez A, Mendoza JL, Taxonera C, Fernandez-Arquero M, Diaz-Rubio M, de la Concha EG, Urcelay E. Role of ATG16L1 Thr300Ala polymorphism in inflammatory bowel disease: A Study in the Spanish population and a meta-analysis. Inflamm Bowel Dis 2009, 15(11):1697-1704. 10.1002/ibd.21001, 19575361.
42. Weedon MN, McCarthy MI, Hitman G, Walker M, Groves CJ, Zeggini E, Rayner NW, Shields B, Owen KR, Hattersley AT, et al. Combining information from common type 2 diabetes risk polymorphisms improves disease prediction. PLoS Med 2006, 3(10):e374. 10.1371/journal.pmed.0030374, 1584415, 17020404.
43. Moore AF, Jablonski KA, McAteer JB, Saxena R, Pollin TI, Franks PW, Hanson RL, Shuldiner AR, Knowler WC, Altshuler D, et al. Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention program. Diabetes 2008, 57(9):2503-2510. 10.2337/db08-0284, 2518503, 18544707.
44. Weersma RK, Stokkers PC, Cleynen I, Wolfkamp SC, Henckaerts L, Schreiber S, Dijkstra G, Franke A, Nolte IM, Rutgeerts P, et al. Confirmation of multiple Crohn's disease susceptibility loci in a large Dutch-Belgian cohort. Am J Gastroenterol 2009, 104(3):630-638. 10.1038/ajg.2008.112, 19174780.
45. Need AC, Kasperaviciute D, Cirulli ET, Goldstein DB. A genome-wide genetic signature of Jewish ancestry perfectly separates individuals with and without full Jewish ancestry in a large random sample of European Americans. Genome Biol 2009, 10(1):R7. 10.1186/gb-2009-10-1-r7, 2687795, 19161619.
46. Jewell NP. Statistics for Epidemiology. 2003, Chapman & Hall/CRC.